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AfﬁnityTo demonstrate the interaction of calpastatin (CS) domain L (CSL) with Cav1.2 channel, we investi-
gated the binding of CSL with various C-terminus-derived peptides at  free, 100 nM, 10 lM, and
1 mM Ca2+ by using the GST pull-down assay method. Besides binding with the IQ motif, CSL was also
found to bind with the PreIQ motif. With increasing [Ca2+], the afﬁnity of the CSL–IQ interaction
gradually decreased, and the afﬁnity of the CSL–PreIQ binding gradually increased. The results sug-
gest that CSL may bind with both the IQ and PreIQ motifs of the Cav1.2 channel in different Ca2+-
dependent manners.
Structured summary of protein interactions:
Cav1.2 IQ binds to CSL by pull down (1, 2)
 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Calpastatin (CS), a speciﬁc endogenous inhibitor of calpain, is
composed of domain XL (CSXL), a unique leading region, domain
L (CSL) of 150–230 amino acid (a.a.) residues in the N-terminal tail,
and four repetitive homologous domains of 140 a.a. residues (do-
mains 1–4) in the C-terminal tail. Domains 1–4 are responsible for
the inhibition of calpain; but CSL does not have calpain-inhibition
activity [1,2]. Based on the N-terminal sequence, CS is classiﬁed
into four types: types I–IV. The CSL domain is present in types I,
II, and III (tissue-type), but not in type IV, which is found in eryth-
rocyte-type CS. The existence of CSL is well conserved in tissue-
type CS of humans, pigs, rabbits, and other mammals [1,2], but
its physiological function remains largely unknown.
Cav1.2 Ca2+ channel activity diminishes in inside-out patches
(run-down) [3,4]. Recently, it has been suggested that CSL and its
fragmental peptides can recover the activity of Cav1.2 in guinea
pig cardiac myocytes dose-dependently after run-down in the in-
side-out conﬁguration of the patch-clamp technique [3–5].Subsequent studies have further conﬁrmed that this activity of
CSL is mediated by a region spanning 11 a.a. residues (a.a. 54–64
in exon 5: EGKPKEHTEPK) [6]. A study using the pull-down assay
method has also shown that CSL integrates with fragments of the
proximal region (IQ region) of the C-terminal tail of the Cav1.2
channel [7]. CSL additionally competes with calmodulin (CaM) as
a partial agonist for the IQ domain in the C-terminal region of
Cav1.2 channels, which may be involved in the Ca2+-dependent
regulations of the channel [7,8]. However, it has not yet been clar-
iﬁed how CSL interacts with the channel and regulates its activity.
Ca2+ channels are the major route of Ca2+ entry into many cells
and play an important role in cellular excitation events involved in
rhythmic ﬁring, muscle contraction, gene expression, hormone
secretion and synaptic transmission. There are many regulators
of such processes, one of which is CaM, a cytoplasmic Ca2+ sensor
that mediates the Ca2+-dependent regulations of the Cav1.2 chan-
nel [9–11]. Numerous studies have suggested that the tethering or
binding sites in the C-terminal tail of Cav1.2 include an isoleucine–
glutamine motif (i.e., the IQ motif, a consensus CaM-binding motif
in many proteins) [9] and a PreIQ motif [10] (referred to as
peptides A and C [9]) (Fig. 1A). Since CSL exists in the cytoplasm
and also reproduces the channel-repriming effect in a concentra-
tion-dependent manner, we hypothesize that CSL may have
A 
B
LRIKTEGNLEQANEELRAIIKKIWKRTSMKLLDQVVPPAGD YATFLIQEYFRKFKKRKEQGL
Wild-type
E/K       I/D                     LL/RR       I/E
PreIQ (1599-1639) IQ (1648-1668)
Wild-type
EF PreIQ IQ
CT1 (1509-1789)
PreIQ-IQ (1599-1668)
PreIQ (1599-1639) IQ (1648-1668)
S 
6 
Fig. 1. Schematic illustrations of the peptides derived from Cav1.2 channel. (A) Amino acid (a.a.) numbers (guinea-pig cardiac Cav1.2) of the derived peptides are shown in
the parentheses. CT1 contains the following regulatory regions (shown as boxes): Ca2+-binding EF-hand motif (EF) and two CaM-binding motifs (preIQ and IQ). (B) Schematic
illustrations of the mutants. The mutated a.a. are also shown in red.
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bances in the calpain-CS system are involved in pathological con-
ditions such as cardiac ischemia, stroke, and brain trauma [2].
These diseases occur with changes in [Ca2+], which may affect
the binding of CSL with Ca2+ channels, including Cav1.2. Compre-
hensive investigation of the Ca2+-dependence of CSL binding with
fragments of Cav1.2 may be beneﬁcial for the treatment of these
diseases.
In the present study, we investigated the Ca2+-dependence of
CSL binding with the C-terminal tail of Cav1.2 channel. To our
knowledge, this is the ﬁrst report conﬁrming CSL binding with Pre-
IQ motif and discussing the Ca2+ dependence of CSL binding with
Cav1.2 Ca2+ channel.
2. Materials and methods
2.1. Preparation of GST-fusion peptides of Cav1.2 and CSL
The cDNA corresponding to the proximal C-terminal tail of
Cav1.2 containing the EF-hand, PreIQ, and IQ motifs (a.a. 1509–
1789, CT1), the PreIQ domain (a.a. 1599–1639), IQ domain (a.a.
1648–1668), PreIQ–IQ (composed of PreIQ, IQ, and the a.a. se-
quence between the two front motifs, a.a. 1599–1668), and mu-
tants [i.e., mutant of the IQ domain I1653E (I/E) and mutant of
the PreIQ domain E1612K (E/K)/I1618D(I/D)/LL1629-1630RR (LL/
RR)] of the guinea pig cardiac Cav1.2 channel (a1C) (Sangon Biotech
Co., Ltd) (GenBank™ AB016287, Fig. 1A) were inserted into
pGEX6p-1 vector. The coding sequence of CSL (a.a. 3–148) from hu-
man CS cDNA (sequence identical to that with GenBank™ acces-
sion number D16217) was inserted into pGEX6p-3 vector. The
identities of all constructs were conﬁrmed by DNA sequencing
prior to use in experiments.
The above vectors were transformed into the Escherichia coli
BL21 (DE3) (Stratagene, La Jolla, CA, USA), and the corresponding
peptides were expressed as glutathione S-transferase (GST)-fusion
proteins. The puriﬁcation of the GST-fusion proteins was as de-
scribed in the previous reports [8,12,13]. The fusion proteins
bound on GS-4B beads were extensively washed with the basic
internal solution (IO solution) at different [Ca2+] (i.e.,  free,100 nM, 10 lM, and 1 mM); these solutions were prepared with
120 mM aspartic acid, 120 mM KOH, 24 mM KCl, 3.5 mM MgCl2,
10 mM HEPES, 3 mM Na2ATP, 1 mM EGTA, and  free, 0.58,
1.02, or 2.8 mM CaCl2, respectively, and titrated to pH 7.4 with
KOH. The [Ca2+] was calculated using WEBMAXC v2.10 software.
As for CSL fusion protein, the GST portion of it was removed by
using the PreScission Protease (GE Healthcare). All steps were
performed on ice or at 4 C. The CSL, CT1, IQ, PreIQ, PreIQ–IQ, mu-
tant PreIQ, and mutant IQ yields were estimated by the Bradford
method using a protein assay kit and bovine serum albumin (BSA)
as the standard. The purity of the peptides was conﬁrmed by den-
sitometry after sodium dodecyl sulfate polyacrylamide gel elec-
trophoresis (SDS–PAGE).
2.2. GST pull-down assay and data analysis
Fusion peptides corresponding to the intracellular regions of
Cav1.2 at saturating concentrations (15 lg) were immobilized on
glutathione Sepharose 4B. Each peptide was incubated with CSL
both in 300 lL of IO solution with  free, 100 nM, 10 lM, or
1 mM Ca2+ for 4 h at 4 C with agitation. Then, these reaction mix-
tures were washed twice with two volumes of the same buffer and
centrifuged at 600 rpm for 3 min at 4 C. Bound CSL and a1C pep-
tides were resuspended in the SDS sample loading buffer at
100 C for 5 min and separated on 15% SDS–polyacrylamide gel.
Proteins were visualized by Coomassie Brilliant Blue R staining.
Protein amounts were quantiﬁed by scanning using the Photoshop
software (Adobe, San Jose, CA, USA), and their optical density was
analyzed by using the Image J software (National Institutes of
Health, Bethesda, MD, USA). The amount of CSL and GST-fusion
peptides was corrected based on the relative optical densities of
0.59 and 0.80 in reference to BSA, respectively [8,13].
Curve ﬁtting of the total bound [CSL] (X) was performed with
the software SigmaPlot 10.0, assuming that free [CSL] in our exper-
imental conditions is nearly equal to total [CSL] [13]. According to
the law of mass action, bound [CSL] (Y) in the one-site model is ex-
pressed by the Hill equation as follows, where Bmax is the maxi-
mum binding, X is the concentration of the free ligand, and Kd is
the apparent dissociation constant.
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For the two-site model, a sum of two Hill’s equations was used
to assume independent binding, where Bmax1, Bmax2, Kd1, and Kd2
denote Bmax and Kd for the high and low afﬁnity sites, respectively.
Y ¼ Bmax1  X=ðKd1 þ XÞBmax2  X=ðKd2 þ XÞ
The data are presented as means ± standard errors (SE). The Stu-
dent’s t-test was used to evaluate the statistical signiﬁcance, and
P < 0.05 was considered signiﬁcant.
3. Results
3.1. Ca2+-dependent binding of CSL to CT1
A previous study has shown that CSL integrates with fragments
of the proximal region of the C-terminal tail of the Cav1.2 channel,
but not with the N-terminal tail, a distal region of the C-terminal
tail, or cytoplasmic loops between repeats I–II, II–III, or III–IV [5].
Thus, the target site for CSL in the Cav1.2 channel could be hypoth-
esized to be located in CT1 (see method). CSL (0.1–30 lM) were
incubated with the same amount of GST–CT1 peptide in the pres-
ence of Ca2+ ranging from  free to 1 mM. Examples of the CSL–CT1
interaction are shown in Fig. 2A, CSL pulled down with CT1 in-
creases concentration- and Ca2+-dependently. Fig. 2B shows the ﬁt-
ted curves of bound CSL against total [CSL], whose parameters are
shown in Table 1. At [Ca2+] 6 10 lM, the binding between CSL
and CT1 appeared to follow the one-site model. At [Ca2+]P 1 mM,  0.1   0.3  1.0   3.0   5.0   10   30   (µM) 
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Fig. 2. CSL binding to CT1 and PreIQ–IQ of Cav1.2 channel. GST pull-down assay for CSL–
curves for CSL–CT1 (B) and CSL–PreIQ–IQ (D) (0.1–30 or 50 lM) at  free, 100 nM, 10 lM a
compared with corresponding bindings at Ca2+-free condition.the binding of CSL was better ﬁtted by the two-site model. When
[Ca2+] was increased to 1 mM, the maximal binding (Bmax1 + Bmax2)
reached over 1 mol CSL/mol peptide (1.27 mol/mol), suggesting
that CT1 could bind more than one CSL molecule at higher [Ca2+]
levels. Meanwhile, the binding afﬁnity, represented as the recipro-
cal of the Kd1 (0.91 lM) and Kd2 (22.26 lM) values, showed that CSL
has high afﬁnity for the presumed binding site 1 and lower afﬁnity
for the site 2 of CT1 at 1 mM Ca2+, suggesting that CSL may bind at
two binding sites of CT1 with different afﬁnities.
3.2. Ca2+-dependent binding of CSL to PreIQ–IQ
We then generated a GST-fusion peptide containing the PreIQ
and IQ fragments named PreIQ–IQ (Fig. 1A). Similar to the binding
features of CT1, at [Ca2+] of  free, 100 nM and 10 lM, the one-site
model described the binding dynamics, while at [Ca2+] of 1 mM,
the two-site model was more appropriate (1.25 for 1 mM)
(Fig. 2C and D, Table 1). Similar to the previous experiment with
CT1, these results suggest that there are two types of CSL binding
sites in the PreIQ–IQ peptide.
3.3. Ca2+-dependent binding of CSL to IQ and PreIQ peptides
To explore the molecular determinants for the CSL–PreIQ–IQ
interaction, we generated two shorter peptides that contain IQ or
PreIQ motif, respectively (Fig. 1). As shown in Fig. 3A, the binding
of CSL with IQ increases with the increasing concentrations of CSL     GST-PreIQ-IQ+ CSL                   
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Table 1
Parameters for the bindings of CSL to GST–CT1 and GST–PreIQ–IQ.
GST–CT1 with CSL GST–PreIQ–IQ with CSL
EGTA 100 (nM) 10 (lM) 1 (mM) EGTA 100 (nM) 10 (lM) 1 (mM)
Bmax1 (mol/mol) 0.47 0.48 0.66 0.58 0.47 0.47 0.7 0.53
Kd1 (lM) 5.95 2.17 2.00 0.91 5.3 5.3 2.82 0.72
Bmax2 (mol/mol) 0.69 0.72
Kd2 (lM) 22.26 22.26
R2 0.98 0.98 0.99 0.99 0.97 0.97 0.99 0.99
Data from the GST pull-down assay shown in Fig. 2 were analyzed with single or double Hill equation by using a software of SigmaPlot 10.0. Kd1 and Kd2: apparent dissociation
constants, Bmax1 and Bmax2: the maximum bindings, R2: coefﬁcient of determination. Blanks in Kd2 and Bmax2 meant a better ﬁt with the single-site model than the double-site
model.
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Fig. 3. CSL binding to IQ and its mutant of Cav1.2 channel. GST pull-down assay for CSL–IQ (A) and CSL–IQ mutant (C). Plots of concentration-dependent binding with ﬁtted
curves for CSL–IQ (B) and CSL–IQ mutant (D) (0.1–30 lM) at  free, 100 nM, 10 lM and 2 mM Ca2+. Symbols are as indicated in each graph (n = 6–8). ⁄P < 0.05, ⁄⁄P < 0.01,
compared with corresponding bindings at Ca2+-free condition.
668 W. Sun et al. / FEBS Letters 588 (2014) 665–671at any [Ca2+] including the Ca2+-free condition, and the ﬁtted curve
moved upward as the [Ca2+] increased (Fig. 3B). At high [Ca2+], Bmax
(0.24 and 0.69 for  free and 1 mM Ca2+, respectively) and Kd
(13.74 and 21.42 for  free and 1 mM Ca2+, respectively) for the
CSL–IQ interaction increased (Table 2). Additionally, the values of
Bmax and Kd at 1 mM Ca2+ are consistent with those of Bmax2 and
Kd2 of CSL binding with CT1 and the PreIQ–IQ peptides (Table 1).
These data suggest that one of the CSL binding sites in the
C-terminal tail of Cav1.2 has the characteristics that the maximum
binding (Bmax) increases, while the afﬁnity decreases with increas-
ing [Ca2+].
After comparing the results of the CSL–PreIQ–IQ and CSL–IQ
interactions, we hypothesized that there may be another bindingsite on the C-terminal tail of the Cav1.2 channel. Therefore, we
examined the binding of CSL with PreIQ peptide. As shown in
Fig. 4, the Ca2+-dependent binding of CSL to PreIQ were identiﬁed.
With [Ca2+] increasing, Bmax (0.18 and 0.50 for  free, 1 mM Ca2+,
respectively) of the CSL–PreIQ interaction increased, whereas the
Kd (17.57 and 6.22 for  free and 1 mM Ca2+, respectively) de-
creased (Table 2). Interestingly, the afﬁnity of the CSL–PreIQ bind-
ing increased with increasing [Ca2+], which differs from the trend
observed for the CSL–IQ interaction. Additionally, the values of Bmax
and Kd at 1 mM Ca2+ are consistent with those of Bmax1 and Kd1 of
the CSL–PreIQ–IQ interaction (Tables 1 and 2), and Bmax for CSL–
PreIQ was lower than that for CSL–IQ, such as Bmax1 is lower than
Bmax2 in the bindings of CSL–CT1 and CSL–PreIQ–IQ.
Table 2
Parameters for the bindings of CSL to GST–IQ, GST–PreIQ and their corresponding mutants.
GST–IQ with CSL Mutant GST–IQ with CSL
EGTA 100 (nM) 10 (lM) 1 (mM) EGTA 100 (nM) 10 (lM) 1 (mM)
Bmax (mol/mol) 0.24 0.37 0.51 0.69 0.09 0.18 0.13 0.07
Kd (lM) 13.74 17.23 17.61 21.42 6.64 13.29 13.36 5.55
R2 0.98 0.99 0.99 0.99 0.98 0.98 0.98 0.97
GST–PreIQ with CSL Mutant GST–PreIQ with CSL
EGTA 100 (nM) 10 (lM) 1 (mM) EGTA 100 (nM) 10 (lM) 1 (mM)
Bmax (mol/mol) 0.18 0.34 0.4 0.5 0.06 0.07 0.09 0.09
Kd (lM) 17.57 13.14 9.22 6.22 5.87 5.95 5.21 5.32
R2 0.99 0.99 0.99 0.99 0.99 0.98 0.99 0.97
Data from the GST pull-down assay shown in Figs. 3 and 4 were analyzed with a single Hill equation by using a software of SigmaPlot 10.0. The meaning of the parameters is
similar to those in Table 1.
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Fig. 4. CSL binding to PreIQ and its mutant of Cav1.2 channel. GST pull-down assay for CSL–PreIQ (A) or CSL–PreIQ mutant (C). Plots of concentration-dependent binding with
ﬁtted curves for CSL–PreIQ (B) and CSL–PreIQ mutant (D) (0.1–30 lM) at  free, 100 nM, 10 lM and 2 mM Ca2+. Symbols are as indicated in each graph (n = 6–8). ⁄P < 0.05,
⁄⁄P < 0.01, compared with corresponding bindings at Ca2+-free condition.
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A previous study [12] examined the effect of the I/E mutation on
the IQ region binding to CaM. Those results indicated that the
mutation nearly completely abolished CaM binding and conﬁrmed
that I1653 in the IQ region interacted with CaM, and that multiple
mutations (E/K-I/D-LL/RR) decreased the afﬁnity of the CaM–PreIQ
interaction, supporting the hypothesis that these a.a. residues are
important for the binding [12]. To demonstrate the binding of
CSL with IQ and PreIQ, we generated mutated IQ and mutated PreIQ
GST-fusion peptides (Fig. 1B). As shown in Fig. 3C and 4C, boundCSL with these two mutants were dramatically decreased. Table 2
shows that the Bmax (s) are much smaller than those of wild-type
IQ and Pre-IQ peptide, and Kd values did not display obvious
Ca2+-dependent changes.
4. Discussion
In the present study, we have found that CSL bound with the
CT1 and PreIQ–IQ peptides derived from the C-terminal tail of
the Cav1.2 channel in a Ca2+-dependent manner. These results
are consistent with the report that CSL bound with CT1 in the
670 W. Sun et al. / FEBS Letters 588 (2014) 665–671presence of EGTA, and the binding was further increased in the
presence of 2 mM Ca2+ [7]. We also demonstrated that CSL bound
to GST–IQ, a shorter version of the PreIQ–IQ peptide, which is con-
sistent with the previous ﬁnding that CSL was co-precipitated with
GST–IQ in the presence of EGTA, and the binding was further in-
creased in 2 mM Ca2+ [7,8].
We also found that CSL bound with the PreIQ motif in a Ca2+-
dependent manner. However, this ﬁnding is inconsistent with
the previous report showing that CSL did not bind with PreIQ
[7,8]. We thought that the variation in the results could be due
to the following reasons: (1) We used 3.75–7.50 times amount of
GST–PreIQ as in the published report (15 vs. 2–4 lg) [8]; (2) Our
incubation time for the CSL–PreIQ interaction was longer (4 vs.
2–3 h) [7,8]; (3) We observed the binding in higher concentration
of CSL (30–50 vs. 2 lM) [7]. Furthermore, such as that mutated IQ
abolished its binding with CSL, mutated preIQ abolished its binding
with CSL at all Ca2+ concentrations, verifying the fact that besides
IQ motif, PreIQ motif might be another CSL binding site on the C-
terminal tail of the Cav1.2 channel.
The one-site model was appropriate for both the CSL–IQ and
CSL–PreIQ interactions. The Ca2+-dependent characteristics of the
Bmax and Kd values were different for CSL binding with IQ and Pre-
IQ peptides: (1) Bmax for IQ binding was larger than that for Pre-
IQ; (2) With the increase in [Ca2+], the afﬁnity of the CSL–IQ
interaction gradually decreased, while the afﬁnity of the CSL–Pre-
IQ interaction gradually increased. The binding parameters of CSL
with CT1 and with PreIQ–IQ were essentially the same when ﬁt-
ted with two-site model at high [Ca2+]. The Bmax and Kd of CSL–IQ
interaction at high [Ca2+] is similar to Bmax2 and Kd2 of the CSL–
PreIQ–IQ interaction, while Bmax and Kd of the CSL–PreIQ interac-
tion seem to be correspond to Bmax1 and Kd1 of the CSL–PreIQ–IQ
interaction. The above data support the view that there are two
CSL binding sites in the C-terminal tail of Cav1.2: One is in IQ,
whose Bmax increased with increasing [Ca2+], but whose binding
afﬁnity decreased; the other is in PreIQ, whose Bmax and afﬁnity
both increased with the increasing [Ca2+]. Since the Bmax of IQ
is larger than that of PreIQ, it can be inferred that at high [Ca2+]
and CSL concentrations, the two binding sites, IQ and PreIQ, might
both be occupied by CSL.
The Cav1.2 is associated with CaM through CaM–PreIQ and
CaM–IQ interactions. Besides sharing the same binding sites,
functionally CSL and CaM also have the similar effects in produc-
ing channel activity in the run-down channels. However, the
maximum effect of CSL was only 14% of the CaM effect; the ef-
fects of CSL and CaM were not simply additive; and CSL even sup-
pressed the effect of CaM in a concentration-dependent manner
[8]. Thus, it is proposed that CSL may compete with CaM for bind-
ing with Cav1.2 as a partial agonist [8], and this kind of compet-
itive binding of CaM and CSL was eventually conﬁrmed on the IQ
motif [8]. Since the afﬁnity of CSL binding with PreIQ increases
with the increase in [Ca2+], it could be inferred that the PreIQ mo-
tif is another potential competitive site for CSL and CaM. CaM
plays a central role in the mediation of Ca2+-dependent facilita-
tion (CDF) and inactivation (CDI) of Ca2+ channel activity. It might
be assumed that, as a partial agonist, CSL may help to activate the
Ca2+ channel when Ca2+/CaM system is down regulated, or miti-
gates the CDF and CDI responses when Ca2+/CaM system is up
regulated, which will be of signiﬁcance to keep the intracellular
Ca2+ homeostatic regulation stable.
The Cav1.2 C-terminal sequences, 1611NEELRAIIKKIWKRTSMK
LLDQV1633 (corresponding a.a. sequence of guinea-pig Cav1.2) [14],
1614LRAIIKKIWKRTSMKLL1630 [15] and 1643TVGKFYATFLIQE
YSRKFKKRK1664 [12] are suggested tobe involved in theCaMbinding.
A recently report has conﬁrmed that mutations in four a.a. residues,
Glu1612, Ile1618, Leu1629 and Leu1630, in PreIQ motif, and one a.a. resi-
due, Ile1653, in IQ motif, signiﬁcantly affect the CaM binding to thepreIQ and IQ peptides, respectively [12]. Similarly, in present study,
we found that the amounts of CSL bindingwith themutants of above
a.a. residues were dramatically decreased, suggesting that those
amino acids are also important for the CSL binding. In structure,
CaM forms a dumbbell-shaped 3-dimentional conformation [16];
however, CSL probably has no-helix region and no obvious secondary
structure, as suggested by in silicon analysis [6]. Another limitation
of the present study is that we do not know the possible effect of
the mutations on the tertiary structure of the peptides. However,
although it is not clear whether the dramatically decreased binding
of CSL is due to structural alternations of the mutants or disturbance
in the electrostatic interaction, our present ﬁnding is consistentwith
the hypothesis that CSL and CaM share the same binding sites [7].
Further studies are needed to examine the structural basis for CSL
binding with Cav1.2 at the CaM-binding sites.
Wash-out of regulatory factors has been suggested as the pri-
mary mechanism responsible for the run-down of the L-type Ca2+
channel [2–4]. A previous report suggested that CS-induced recov-
ery of Ca2+ channel activity after run-down is related to the C-ter-
minal region of the Cav1.2 channel, which includes the PreIQ and
IQ motifs [2–4,14]. Therefore, binding of CSL with IQ and PreIQ
may be one of the mechanisms required to maintain the basal
activity of the Ca2+ channel.
The calpain/CS balance may become impaired in pathological
conditions such as cardiac ischemia, stroke, and brain trauma
[2,17]. CS is composed of multiple domains, including CSXL, CSL
and domains 1–4 [1,8]. During cardiac ischemia and reperfusion
injury, the full-length CS may be degraded [17], and the CSL may
be released. Based on the ﬁnding that CSL binds with the Cav1.2
channel in Ca2+-dependent manners, it can be inferred that a disor-
der of the Ca2+ channel function may be related with the Ca2+-
dependent binding of CSL with IQ and PreIQ motifs. The concentra-
tion of CS in cardiac myocytes is estimated to be approximately
1 lM [18]. However, because CS localizes in the area of the Z-disk
[19], around which Cav1.2 channels in the T-tubular system are
also localized, it could be inferred that the concentration of CS near
the channel might be higher than the average level estimated. Thus
it is reasonable to think that the concentration of CS could be high
enough to affect the activity of the Cav1.2 channel by directly
interacting with it.
In conclusion, we found that CSL, which was reported to
affect the activity of Cav1.2, may directly interact with the IQ
and PreIQ motifs of the Cav1.2 C-terminal tail in Ca2+-dependent
manners.
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